- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Tags
Industry Analysis Technology Transfer patent Partnering agriculture Sustainability BIO International Convention Food One-on-One's Plant biotechnology Biotechnology Industry Benefits of biotech crops biotechnology Health Care climate change biofuels global food crisis Biofuel Technology biotech industry biofuelAuthors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas, CFA
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Tracy Cooley
Author Archive: Kelly Cappio
Kelly is the Manager of Vaccines and Biodefense Policy at BIO. In her role, she advocates for policies, regulations, and legislation that improve public health through immunization and emergency preparedness. Originally from the small town of Culpeper, Virginia, Kelly enjoys traveling to new places and living in big cities. She moved to Washington, D.C. in 2009 to pursue a master’s degree in public health from the George Washington University and graduated in May 2011. In her spare time, she loves to read, play tennis, horseback ride, and most of all, spend time with her husband, Matt, and 7-lb poodle, Maeby.
Latest Posts
National Infant Immunization Week, April 21-28
Routine immunization of one birth cohort (i.e. people born in a particular year) during childhood prevents about 20 million cases of disease and 42,000 deaths in the U.S. These statistics are staggering, especially when we consider how far vaccinology and preventive medicine have come in such a short time period. Today, vaccines help protect children against 14 diseases before the age of two. Many diseases that parents once feared have been long forgotten. In the Read More >
As Vaccine Exemptions Rise, Risk of Outbreaks Intensifies
Generally, we think of vaccines as protecting the vaccinated. We often forget that vaccines, when administered to enough people, protect those in the community who cannot be vaccinated due to certain health conditions, who are too young to be vaccinated, or who experience vaccine failure. This “herd immunity,” as it’s called, is analogous to the concept of ‘safety in numbers’ and is critical to outbreak prevention. However, as reported by Valerie Bauerlein and Betsy McKay Read More >
World Pneumonia Day: November 12
November 12 marks World Pneumonia Day, a campaign to educate the public about this disease and to advocate for global action to treat and prevent it. Pneumonia is the leading cause of death globally for children under the age of 5, claiming the lives of more than 1.5 million children annually. Pneumonia is also largely a vaccine-preventable disease. Since the introduction of pneumococcal vaccines in the U.S. in 2000, morbidity and mortality from pneumonia have Read More >
Ten Years After 9/11 and the Anthrax Attacks
Yesterday, the U.S. Senate Committee on Homeland Security and Governmental Affairs held a hearing entitled, “Ten Years After 9/11 and the Anthrax Attacks: Protecting Against Biological Threats”. As stated by Chairman Lieberman in his opening remarks, the goal of the hearing was to examine whether the federal government “has developed the tools we need to respond effectively to a bioterror attack or naturally-occurring pandemic disease, to develop and disseminate vaccines and antibiotics, and to respond Read More >
Anthrax Attacks 10 Year Anniversary: BioCentury Looks at Preparedness
A decade ago in the weeks following the terrorist attacks of September 11th, the nation faced yet another terrorist threat. Letters containing anthrax spores were mailed to two U.S. senators and several media outlets, killing five people and sickening 17 others. It was the deadliest biological attack in U.S. history, and resulted in the largest and most expensive investigation in FBI history. Biosecurity experts believe that another bioterrorist attack is imminent, and the impact could Read More >
